140 related articles for article (PubMed ID: 4059474)
1. Weekly monitoring of dexamethasone suppression response in depression: its relationship to change of body weight and psychopathology.
Gerken A; Maier W; Holsboer F
Psychoneuroendocrinology; 1985; 10(3):261-71. PubMed ID: 4059474
[TBL] [Abstract][Full Text] [Related]
2. Dexamethasone suppression test and sleep deprivation in endogenous depression.
Kuhs H
J Affect Disord; 1985 Sep; 9(2):121-6. PubMed ID: 2932484
[TBL] [Abstract][Full Text] [Related]
3. Plasma corticosterone and cortisol following dexamethasone in psychiatric patients.
Arana GW; Wilens TE; Baldessarini RJ
Psychoneuroendocrinology; 1985; 10(1):49-60. PubMed ID: 4001277
[TBL] [Abstract][Full Text] [Related]
4. Serial assessment of corticotropin-releasing hormone response after dexamethasone in depression. Implications for pathophysiology of DST nonsuppression.
Holsboer F; von Bardeleben U; Wiedemann K; Müller OA; Stalla GK
Biol Psychiatry; 1987 Feb; 22(2):228-34. PubMed ID: 3028512
[No Abstract] [Full Text] [Related]
5. The dexamethasone suppression and metyrapone tests in depression.
Morphy MA; Fava GA; Perini GI; Molnar G; Zielezny M; Lisansky J
Psychiatry Res; 1985 Jun; 15(2):153-8. PubMed ID: 3862146
[TBL] [Abstract][Full Text] [Related]
6. Number of cortisol time-points and dexamethasone suppression test sensitivity for major depression.
Extein I; Pottash AL; Gold MS
Psychoneuroendocrinology; 1985; 10(3):281-8. PubMed ID: 4059475
[TBL] [Abstract][Full Text] [Related]
7. The dexamethasone suppression test in panic disorder and major depressive episodes.
Faludi G; Kaskó M; Perényi A; Arató M; Frecska E
Biol Psychiatry; 1986 Sep; 21(11):1008-14. PubMed ID: 3741916
[TBL] [Abstract][Full Text] [Related]
8. The influence of weight loss on the dexamethasone suppression test.
Yerevanian BI; Baciewicz GJ; Iker HP; Privitera MR
Psychiatry Res; 1984 Jun; 12(2):155-60. PubMed ID: 6591220
[TBL] [Abstract][Full Text] [Related]
9. The dexamethasone suppression test in depressed and non-depressed geriatric medical inpatients.
Magni G; Schifano F; De Leo D; De Dominicis MG; Garbin A; Zangaglia O
Acta Psychiatr Scand; 1986 May; 73(5):511-4. PubMed ID: 3751656
[TBL] [Abstract][Full Text] [Related]
10. Association performance and the DST.
Demeter E; Rihmer Z; Arato M; Frecska E
Psychiatry Res; 1986 Jul; 18(3):289-90. PubMed ID: 3749388
[No Abstract] [Full Text] [Related]
11. Age effects in serial hypothalamic-pituitary-adrenal monitoring.
Greden JF; Flegel P; Haskett R; Dilsaver S; Carroll BJ; Grunhaus L; Genero N
Psychoneuroendocrinology; 1986; 11(2):195-204. PubMed ID: 3749402
[TBL] [Abstract][Full Text] [Related]
12. The dexamethasone suppression test in agoraphobia.
Peterson GA; Ballenger JC; Cox DP; Hucek A; Lydiard RB; Laraia MT; Trockman C
J Clin Psychopharmacol; 1985 Apr; 5(2):100-2. PubMed ID: 3988966
[TBL] [Abstract][Full Text] [Related]
13. Reported weight loss and dexamethasone nonsuppression in depressed patients. A negative study.
Gwirtsman HE; Roy-Byrne P; Gitlin MJ; Halaris A; Ahles S
J Affect Disord; 1985 Sep; 9(2):193-6. PubMed ID: 2932495
[TBL] [Abstract][Full Text] [Related]
14. What does the dexamethasone suppression test identify?
Krishnan KR; France RD; Pelton S; McCann UD; Manepalli AN; Davidson JR
Biol Psychiatry; 1985 Sep; 20(9):957-64. PubMed ID: 4027315
[TBL] [Abstract][Full Text] [Related]
15. The dex/CRH test--is it better than the DST?
Watson S; Gallagher P; Smith MS; Ferrier IN; Young AH
Psychoneuroendocrinology; 2006 Aug; 31(7):889-94. PubMed ID: 16701957
[TBL] [Abstract][Full Text] [Related]
16. Pretreatment DST and hypothalamic-pituitary-adrenocortical function in depressed patients and comparison groups. A multicenter study.
Stokes PE; Stoll PM; Koslow SH; Maas JW; Davis JM; Swann AC; Robins E
Arch Gen Psychiatry; 1984 Mar; 41(3):257-67. PubMed ID: 6367690
[TBL] [Abstract][Full Text] [Related]
17. [Dexamethasone suppression test (DST): clinical use in psychiatry].
Morrissette L; Boucher H
Union Med Can; 1986 Jan; 115(1):58-63. PubMed ID: 3952894
[No Abstract] [Full Text] [Related]
18. Prediction of outcome in depressed patients by weekly monitoring with the dexamethasone suppression test.
Schweitzer I; Maguire KP; Gee AH; Tiller JW; Biddle N; Davies B
Br J Psychiatry; 1987 Dec; 151():780-4. PubMed ID: 3502804
[TBL] [Abstract][Full Text] [Related]
19. Platelet MAO activity and the dexamethasone suppression test in bipolar depression.
Bagdy G; Rihmer Z; Frecska E; Szádóczky E; Arató M
Psychoneuroendocrinology; 1986; 11(1):117-20. PubMed ID: 3704065
[TBL] [Abstract][Full Text] [Related]
20. Neuroendocrine aspects of primary endogenous depression. II. Serum dexamethasone concentrations and hypothalamic-pituitary-adrenal cortical activity as determinants of the dexamethasone suppression test response.
Poland RE; Rubin RT; Lesser IM; Lane LA; Hart PJ
Arch Gen Psychiatry; 1987 Sep; 44(9):790-5. PubMed ID: 3632252
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
